A fourth dose of mRNA-based vaccine may be warranted in some kidney transplant recipients
How a potent antifibrotic peptide works and why it could reverse scarring in multiple organs
10 January 2022Death rates among people with type 2 diabetes have declined in many countries including Australia, Canada and the US
10 January 2022A fourth dose of mRNA-based vaccine may be warranted in some kidney transplant recipients
A case series published in Annals of Internal Medicine finds that a fourth dose of an mRNA-based vaccine produces a satisfactory antibody response in some kidney transplant recipients who did not respond adequately after 3 previous doses. These findings support the use of a fourth vaccine dose for such patients.
